Morgan Stanley Cerus Corp Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Cerus Corp stock. As of the latest transaction made, Morgan Stanley holds 3,350,578 shares of CERS stock, worth $6.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,350,578

Previous 2,927,047 14.47%

Holding current value

$6.06 Million

Previous $5.09 Million 1.3%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$1.52 - $2.03 $643,767 - $859,767	423,531 Added 14.47%	3,350,578 $5.16 Million
Q3 2024 Nov 14, 2024	BUY	$1.7 - $2.39 $1.13 Million - $1.59 Million	664,732 Added 29.38%	2,927,047 $5.09 Million
Q2 2024 Oct 17, 2024	BUY	$1.62 - $2.04 $404,810 - $509,761	249,883 Added 12.42%	2,262,315 $3.98 Million
Q2 2024 Aug 14, 2024	BUY	$1.62 - $2.04 $404,810 - $509,761	249,883 Added 12.42%	2,262,315 $3.98 Million
Q1 2024 Oct 17, 2024	SELL	$1.66 - $2.42 $414,805 - $604,716	-249,883 Reduced 11.05%	2,012,432 $3.8 Million
Q1 2024 Aug 16, 2024	BUY	$1.66 - $2.42 $1.02 Million - $1.48 Million	612,116 Added 43.71%	2,012,432 $3.8 Million
Q1 2024 May 15, 2024	BUY	$1.66 - $2.42 $1.02 Million - $1.48 Million	612,116 Added 43.71%	2,012,432 $3.8 Million
Q4 2023 Aug 16, 2024	SELL	$1.25 - $2.35 $1.08 Million - $2.03 Million	-861,999 Reduced 38.1%	1,400,316 $3.02 Million
Q4 2023 Feb 13, 2024	BUY	$1.25 - $2.35 $580,651 - $1.09 Million	464,521 Added 49.64%	1,400,316 $3.02 Million
Q3 2023 Nov 15, 2023	BUY	$1.5 - $3.07 $24,103 - $49,331	16,069 Added 1.75%	935,795 $1.52 Million
Q2 2023 Aug 14, 2023	SELL	$1.79 - $2.9 $1.09 Million - $1.76 Million	-608,324 Reduced 39.81%	919,726 $2.26 Million
Q1 2023 May 15, 2023	BUY	$2.65 - $3.81 $2.38 Million - $3.42 Million	898,596 Added 142.76%	1,528,050 $4.54 Million
Q4 2022 Feb 14, 2023	SELL	$3.38 - $4.22 $223,810 - $279,431	-66,216 Reduced 9.52%	629,454 $2.3 Million
Q3 2022 Nov 14, 2022	SELL	$3.43 - $5.83 $276,293 - $469,618	-80,552 Reduced 10.38%	695,670 $2.5 Million
Q2 2022 Oct 27, 2022	BUY	$4.41 - $5.69 $444,034 - $572,914	100,688 Added 14.9%	776,222 $4.11 Million
Q2 2022 Aug 15, 2022	BUY	$4.41 - $5.69 $444,034 - $572,914	100,688 Added 14.9%	776,222 $4.11 Million
Q1 2022 Oct 27, 2022	SELL	$4.81 - $6.99 $484,309 - $703,809	-100,688 Reduced 12.97%	675,534 $3.71 Million
Q1 2022 May 13, 2022	BUY	$4.81 - $6.99 $617,454 - $897,299	128,369 Added 23.46%	675,534 $3.71 Million
Q4 2021 Feb 14, 2022	SELL	$5.97 - $7.93 $386,151 - $512,928	-64,682 Reduced 10.57%	547,165 $3.73 Million
Q3 2021 Nov 15, 2021	BUY	$4.79 - $6.68 $2.93 Million - $4.09 Million	611,847 New	611,847 $3.73 Million

Others Institutions Holding CERS

# of Institutions

159

Shares Held

146M

Call Options Held

48.6K

Put Options Held

8.7K

View Full List

About CERUS CORP

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $321M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

More about CERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account